1887

Microbial Genomics logo

Volume 8, Issue 3

Global evolutionary dynamics and resistome analysis of ribotype 017 Open Access

Abstract

PCR ribotype (RT) 017 ranks among the most successful strains of in the world. In the past three decades, it has caused outbreaks on four continents, more than other ‘epidemic’ strains, but our understanding of the genomic epidemiology underpinning the spread of RT 017 is limited. Here, we performed high-resolution phylogenomic and Bayesian evolutionary analyses on an updated and more representative dataset of 282 non-clonal RT 017 isolates collected worldwide between 1981 and 2019. These analyses place an estimated time of global dissemination between 1953 and 1983 and identified the acquisition of the -positive transposon Tn as a key factor behind global emergence. This coincided with the introduction of clindamycin, a key inciter of infection, into clinical practice in the 1960s. Based on the genomic data alone, the origin of RT 017 could not be determined; however, geographical data and records of population movement suggest that RT 017 had been moving between Asia and Europe since the Middle Ages and was later transported to North America around 1860 (95 % confidence interval: 1622–1954). A focused epidemiological study of 45 clinical RT 017 genomes from a cluster in a tertiary hospital in Thailand revealed that the population consisted of two groups of multidrug-resistant (MDR) RT 017 and a group of early, non-MDR RT 017. The significant genomic diversity within each MDR group suggests that although they were all isolated from hospitalized patients, there was probably a reservoir of RT 017 in the community that contributed to the spread of this pathogen.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): AMR , Clostridioides difficile , evolution , outbreaks , population and ribotype 017
Funding
This study was supported by the:
  • Edith Cowan University
    • Principle Award Recipient: DeirdreA Collins
  • National Health and Medical Research Council (Award APP1138257)
    • Principle Award Recipient: DanielR Knight
  • Raine Medical Research Foundation (Award RPG002-19)
    • Principle Award Recipient: DanielR Knight
  • Mahidol University
    • Principle Award Recipient: KorakritImwattana
© 2022 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.000792
2022-03-22
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/mgen/8/3/mgen000792.html?itemId=/content/journal/mgen/10.1099/mgen.0.000792&mimeType=html&fmt=ahah

References

  1. Imwattana K, Knight DR, Kullin B, Collins DA, Putsathit P et al. Clostridium difficile ribotype 017 - characterization, evolution and epidemiology of the dominant strain in Asia. Emerg Microbes Infect 2019; 8:796–807 [View Article] [PubMed]
     [Google Scholar]
  2. Kim J, Kim Y, Pai H. Clinical characteristics and treatment outcomes of Clostridium difficile infections by PCR Ribotype 017 and 018 Strains. PLoS One 2016; 11:e0168849 [View Article] [PubMed]
     [Google Scholar]
  3. Kim J, Pai H, Seo MR, Kang JO. Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections. BMC Infect Dis 2012; 12:109 [View Article] [PubMed]
     [Google Scholar]
  4. Goorhuis A, Debast SB, Dutilh JC, van Kinschot CM, Harmanus C et al. Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital. Clin Infect Dis 2011; 53:860–869 [View Article] [PubMed]
     [Google Scholar]
  5. Imwattana K, Knight DR, Kullin B, Collins DA, Putsathit P et al. Antimicrobial resistance in Clostridium difficile ribotype 017. Expert Rev Anti Infect Ther 2020; 18:17–25 [View Article] [PubMed]
     [Google Scholar]
  6. Lyerly DM, Saum KE, MacDonald DK, Wilkins TD. Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun 1985; 47:349–352 [View Article] [PubMed]
     [Google Scholar]
  7. Lyerly DM, Sullivan NM, Wilkins TD. Enzyme-linked immunosorbent assay for Clostridium difficile toxin A. J Clin Microbiol 1983; 17:72–78 [View Article] [PubMed]
     [Google Scholar]
  8. al-Barrak A, Embil J, Dyck B, Olekson K, Nicoll D et al. An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital. Can Commun Dis Rep 1999; 25:65–69 [PubMed]
     [Google Scholar]
  9. Knight DR, Imwattana K, Kullin B, Guerrero-Araya E, Paredes-Sabja D et al. Major genetic discontinuity and novel toxigenic species in Clostridioides difficile taxonomy. elife 2021; 10:e64325 [View Article] [PubMed]
     [Google Scholar]
  10. Putsathit P, Maneerattanaporn M, Piewngam P, Kiratisin P, Riley TV. Prevalence and molecular epidemiology of Clostridium difficile infection in Thailand. New Microbes New Infect 2017; 15:27–32 [View Article] [PubMed]
     [Google Scholar]
  11. Imwattana K, Wangroongsarb P, Riley TV. High prevalence and diversity of tcdA-negative and tcdB-positive, and non-toxigenic, Clostridium difficile in Thailand. Anaerobe 2019; 57:4–10 [View Article] [PubMed]
     [Google Scholar]
  12. Riley TV, Collins DA, Karunakaran R, Kahar MA, Adnan A et al. High prevalence of toxigenic and nontoxigenic Clostridium difficile strains in Malaysia. J Clin Microbiol 2018; 56:e00170-18 [View Article] [PubMed]
     [Google Scholar]
  13. Collins DA, Gasem MH, Habibie TH, Arinton IG, Hendriyanto P et al. Prevalence and molecular epidemiology of Clostridium difficile infection in Indonesia. New Microbes New Infect 2017; 18:34–37 [View Article] [PubMed]
     [Google Scholar]
  14. Rupnik M, Kato N, Grabnar M, Kato H. New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J Clin Microbiol 2003; 41:1118–1125 [View Article] [PubMed]
     [Google Scholar]
  15. Arvand M, Hauri AM, Zaiss NH, Witte W, Bettge-Weller G. Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany. Euro Surveill 2009; 14:45 [View Article]
     [Google Scholar]
  16. Cairns MD, Preston MD, Lawley TD, Clark TG, Stabler RA et al. Genomic epidemiology of a protracted hospital outbreak caused by a toxin a-negative Clostridium difficile sublineage PCR ribotype 017 strain in London, England. J Clin Microbiol 2015; 53:3141–3147 [View Article] [PubMed]
     [Google Scholar]
  17. Åkerlund T, Alefjord I, Dohnhammar U, Struwe J, Norén T et al. Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR-ribotypes 012, 017 and 046 in Sweden, 2008 and 2009. Euro Surveill 2011; 16:10 [View Article]
     [Google Scholar]
  18. Isidro J, Santos A, Nunes A, Borges V, Silva C et al. Imipenem resistance in Clostridium difficile ribotype 017, Portugal. Emerg Infect Dis 2018; 24:741–745 [View Article] [PubMed]
     [Google Scholar]
  19. Drudy D, Harnedy N, Fanning S, O’Mahony R, Kyne L. Isolation and characterisation of toxin A-negative, toxin B-positive Clostridium difficile in Dublin, Ireland. Clin Microbiol Infect 2007; 13:298–304 [View Article] [PubMed]
     [Google Scholar]
  20. Goorhuis A, Legaria MC, van den Berg RJ, Harmanus C, Klaassen CHW et al. Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina. Clin Microbiol Infect 2009; 15:1080–1086 [View Article] [PubMed]
     [Google Scholar]
  21. Wang B, Peng W, Zhang P, Su J. The characteristics of Clostridium difficile ST81, a new PCR ribotype of toxin A- B+ strain with high-level fluoroquinolones resistance and higher sporulation ability than ST37/PCR ribotype 017. FEMS Microbiol Lett 2018; 365:17 [View Article] [PubMed]
     [Google Scholar]
  22. Qin J, Dai Y, Ma X, Wang Y, Gao Q et al. Nosocomial transmission of Clostridium difficile genotype ST81 in a general teaching hospital in China traced by whole genome sequencing. Sci Rep 2017; 7:9627 [View Article] [PubMed]
     [Google Scholar]
  23. Senoh M, Kato H, Fukuda T, Niikawa A, Hori Y et al. Predominance of PCR-ribotypes, 018 (smz) and 369 (trf) of Clostridium difficile in Japan: a potential relationship with other global circulating strains?. J Med Microbiol 2015; 64:1226–1236 [View Article] [PubMed]
     [Google Scholar]
  24. Imwattana K, Kiratisin P, Riley TV, Knight DR. Genomic basis of antimicrobial resistance in non-toxigenic Clostridium difficile in Southeast Asia. Anaerobe 2020; 66:102290 [View Article] [PubMed]
     [Google Scholar]
  25. Cairns MD, Preston MD, Hall CL, Gerding DN, Hawkey PM et al. Comparative genome analysis and global phylogeny of the toxin variant Clostridium difficile PCR ribotype 017 reveals the evolution of two independent sublineages. J Clin Microbiol 2017; 55:865–876 [View Article] [PubMed]
     [Google Scholar]
  26. Xu X, Luo Y, Chen H, Song X, Bian Q et al. Genomic evolution and virulence association of Clostridioides difficile sequence type 37 (ribotype 017) in China. Emerg Microbes Infect 2021; 10:1331–1345 [View Article] [PubMed]
     [Google Scholar]
  27. Imwattana K, Putsathit P, Knight DR, Kiratisin P, Riley TV. Molecular characterization of, and antimicrobial resistance in, Clostridioides difficile from Thailand, 2017-2018. Microb Drug Resist 2021; 27:1505–1512 [View Article] [PubMed]
     [Google Scholar]
  28. Vernon JJ. Multidrug resistant Clostridioides difficile: the Presence of Antimicrobial Resistance Determinants in Historical and Contemporaneous Isolates, and the Impact of Fluoroquinolone Resistance Development on PCR Ribotype 027 Fitness University of Leeds; 2019
     [Google Scholar]
  29. Inouye M, Dashnow H, Raven L-A, Schultz MB, Pope BJ et al. SRST2: Rapid genomic surveillance for public health and hospital microbiology labs. Genome Med 2014; 6:11 [View Article] [PubMed]
     [Google Scholar]
  30. Knight DR, Squire MM, Collins DA, Riley TV. Genome analysis of Clostridium difficile PCR ribotype 014 lineage in australian pigs and humans reveals a diverse genetic repertoire and signatures of long-range interspecies transmission. Front Microbiol 2016; 7:2138 [View Article] [PubMed]
     [Google Scholar]
  31. He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF et al. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci U S A 2010; 107:7527–7532 [View Article] [PubMed]
     [Google Scholar]
  32. Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 2017; 13:e1005595 [View Article] [PubMed]
     [Google Scholar]
  33. Wick RR, Schultz MB, Zobel J, Holt KE. Bandage: interactive visualization of de novo genome assemblies. Bioinformatics 2015; 31:3350–3352 [View Article] [PubMed]
     [Google Scholar]
  34. Tatusova T, DiCuccio M, Badretdin A, Chetvernin V, Nawrocki EP et al. NCBI prokaryotic genome annotation pipeline. Nucleic Acids Res 2016; 44:6614–6624 [View Article] [PubMed]
     [Google Scholar]
  35. Gupta SK, Padmanabhan BR, Diene SM, Lopez-Rojas R, Kempf M et al. ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob Agents Chemother 2014; 58:212–220 [View Article] [PubMed]
     [Google Scholar]
  36. Cingolani P, Platts A, Wang LL, Coon M, Nguyen T et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff. Fly (Austin) 2014; 6:80–92 [View Article]
     [Google Scholar]
  37. Danecek P, Auton A, Abecasis G, Albers CA, Banks E et al. The variant call format and VCFtools. Bioinformatics 2011; 27:2156–2158 [View Article] [PubMed]
     [Google Scholar]
  38. Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res 2015; 43:e15 [View Article] [PubMed]
     [Google Scholar]
  39. Eyre DW, Walker AS. Clostridium difficile surveillance: harnessing new technologies to control transmission. Expert Rev Anti Infect Ther 2013; 11:1193–1205 [View Article] [PubMed]
     [Google Scholar]
  40. Didelot X, Eyre DW, Cule M, Ip CL, Ansari M et al. Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biol 2012; 13:R118 [View Article]
     [Google Scholar]
  41. Didelot X, Croucher NJ, Bentley SD, Harris SR, Wilson DJ. Bayesian inference of ancestral dates on bacterial phylogenetic trees. Nucleic Acids Res 2018; 46:22 [View Article] [PubMed]
     [Google Scholar]
  42. Letunic I, Bork P. Interactive Tree Of Life (iTOL) v4: recent updates and new developments. Nucleic Acids Res 2019; 47:W256–W259 [View Article] [PubMed]
     [Google Scholar]
  43. Argimón S, Abudahab K, Goater RJE, Fedosejev A, Bhai J et al. Microreact: visualizing and sharing data for genomic epidemiology and phylogeography. Microb Genom 2016; 2:e000093 [View Article] [PubMed]
     [Google Scholar]
  44. Imwattana K, Putsathit P, Leepattarakit T, Kiratisin P, Riley TV. Mild or malign: clinical characteristics and outcomes of Clostridium difficile infection in Thailand. J Clin Microbiol 2020; 58:e01217-20 [View Article] [PubMed]
     [Google Scholar]
  45. Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003; 52:696–704 [View Article] [PubMed]
     [Google Scholar]
  46. Jain C, Rodriguez-R LM, Phillippy AM, Konstantinidis KT, Aluru S. High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundaries. Nat Commun 2018; 9:5114 [View Article]
     [Google Scholar]
  47. Tonkin-Hill G, MacAlasdair N, Ruis C, Weimann A, Horesh G et al. Producing polished prokaryotic pangenomes with the panaroo pipeline. Genome Biol 2020; 21:180 [View Article]
     [Google Scholar]
  48. Brynildsrud O, Bohlin J, Scheffer L, Eldholm V. Erratum to: Rapid scoring of genes in microbial pan-genome-wide association studies with Scoary. Genome Biol 2016; 17:262 [View Article] [PubMed]
     [Google Scholar]
  49. Tasteyre A, Barc M-C, Karjalainen T, Dodson P, Hyde S et al. A Clostridium difficile gene encoding flagellin. Microbiology 2000; 146:957–966 [View Article]
     [Google Scholar]
  50. Purcell EB, McKee RW, McBride SM, Waters CM, Tamayo R. Cyclic diguanylate inversely regulates motility and aggregation in Clostridium difficile. J Bacteriol 2012; 194:3307–3316 [View Article]
     [Google Scholar]
  51. Geric B, Carman RJ, Rupnik M, Genheimer CW, Sambol SP et al. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis 2006; 193:1143–1150 [View Article] [PubMed]
     [Google Scholar]
  52. Bordeleau E, Fortier LC, Malouin F, Burrus V. c-di-GMP turn-over in Clostridium difficile is controlled by a plethora of diguanylate cyclases and phosphodiesterases. PLoS Genet 2011; 7:e1002039 [View Article] [PubMed]
     [Google Scholar]
  53. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 2011; 7:539 [View Article] [PubMed]
     [Google Scholar]
  54. Dingle KE, Elliott B, Robinson E, Griffiths D, Eyre DW et al. Evolutionary history of the Clostridium difficile pathogenicity locus. Genome Biol Evol 2014; 6:36–52 [View Article] [PubMed]
     [Google Scholar]
  55. Meyers BR, Kaplan K, Weinstein L. Microbiological and pharmacological behavior of 7-chlorolincomycin. Appl Microbiol 1969; 17:653–657 [View Article] [PubMed]
     [Google Scholar]
  56. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 2013; 45:109–113 [View Article] [PubMed]
     [Google Scholar]
  57. Lynch JP 3rd, File TM Jr, Zhanel GG. Levofloxacin for the treatment of community-acquired pneumonia. Expert Rev Anti Infect Ther 2006; 4:725–742 [View Article] [PubMed]
     [Google Scholar]
  58. Khanafer N, Daneman N, Greene T, Simor A, Vanhems P et al. Susceptibilities of clinical Clostridium difficile isolates to antimicrobials: a systematic review and meta-analysis of studies since 1970. Clin Microbiol Infect 2018; 24:110–117 [View Article] [PubMed]
     [Google Scholar]
  59. Daigle DM, Hughes DW, Wright GD. Prodigious substrate specificity of AAC(6’)-APH(2"), an aminoglycoside antibiotic resistance determinant in enterococci and staphylococci. Chem Biol 1999; 6:99–110 [View Article] [PubMed]
     [Google Scholar]
  60. Neumann-Schaal M, Jahn D, Schmidt-Hohagen K. Metabolism the difficile way: the key to the success of the pathogen Clostridioides difficile. Front Microbiol 2019; 10:219 [View Article] [PubMed]
     [Google Scholar]
  61. Bateman A, Martin MJ, Orchard S, Magrane M, Agivetova R et al. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res 2021; 49:D480–D489
     [Google Scholar]
  62. Rodriguez-Palacios A, Stämpfli HR, Duffield T, Peregrine AS, Trotz-Williams LA et al. Clostridium difficile PCR ribotypes in calves, Canada. Emerg Infect Dis 2006; 12:1730–1736 [View Article] [PubMed]
     [Google Scholar]
  63. Lim SC, Knight DR, Riley TV. Clostridium difficile and one health. Clin Microbiol Infect 2020; 26:857–863 [View Article] [PubMed]
     [Google Scholar]
  64. Putsathit P, Neela VK, Joseph NMS, Ooi PT, Ngamwongsatit B et al. Molecular epidemiology of Clostridium difficile isolated from piglets. Vet Microbiol 2019; 237:108408 [View Article] [PubMed]
     [Google Scholar]
  65. Guh AY, Mu Y, Winston LG, Johnston H, Olson D et al. Trends in U.S. burden of Clostridioides difficile infection and outcomes. N Engl J Med 2020; 382:1320–1330 [View Article] [PubMed]
     [Google Scholar]
  66. Nagy E. What do we know about the diagnostics, treatment and epidemiology of Clostridioides (Clostridium) difficile infection in Europe?. J Infect Chemother 2018; 24:164–170 [View Article] [PubMed]
     [Google Scholar]
  67. Stone NE, Sidak-Loftis LC, Sahl JW, Vazquez AJ, Wiggins KB et al. More than 50% of Clostridium difficile Isolates from pet dogs in Flagstaff, USA, carry toxigenic genotypes. PLoS One 2016; 11:e0164504 [View Article] [PubMed]
     [Google Scholar]
  68. Weese JS, Finley R, Reid-Smith RR, Janecko N, Rousseau J. Evaluation of Clostridium difficile in dogs and the household environment. Epidemiol Infect 2010; 138:1100–1104 [View Article] [PubMed]
     [Google Scholar]
  69. Bradley RS. Chapter 3 - dating methods I. In Bradley RS. eds Paleoclimatology, 3rd ed. Academic Press; 2015 pp 55–101
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.000792
Loading
Global evolutionary dynamics and resistome analysis of Clostridioides difficile ribotype 017
M Gen 8, 000792 (2022); https://doi.org/10.1099/mgen.0.000792
/content/journal/mgen/10.1099/mgen.0.000792
/content/journal/mgen/10.1099/mgen.0.000792
Loading

Data & Media loading...

Supplements

Loading data from figshare Loading data from figshare

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error